作者：
Veneziale,R.W. [1]
;
Kishnani,N.S. [2]
;
Nelson,J. [3]
;
Resendez,J.C. [4]
;
Frank,D.W. [5]
;
Cai,X.-Y. [6]
;
Xie,L. [7]
;
Cullen,C. [8]
;
Frugone,C.A. [9]
;
Rosenfeld,C. [10]
;
Hubbell,J. [11]
;
Maxwell,S.E. ;
Sugarman,B.J. ;
Hutchins,B. ;
Maneval,D. ;
Treinen,K.A.
作者单位：
Merck Research Laboratories, Summit, NJ, United States
[1]
Formally at Schering-Plough Research Institute, Lafayette, NJ, United States
[2]
Merck Research Laboratories, Kenilworth, NJ, United States
[3]
Merck Research Laboratories, West Point, PA, United States
[4]
Merck Research Laboratories, Union, NJ, United States
[5]
Charles River Preclinical Services Nevada, Reno, NV, United States
[6]
Halozyme Therapeutics, Inc., San Diego, CA, United States
[7]
Merck Research Laboratories, Palo Alto, CA, United States
[8]
Biopharmaceutical Development, San Diego, CA, United States
[9]
Pfizer Inc., Drug Safety Research and Development, 401 North Middletown Road, Pearl River, NY 10965
[10]
MPI Research, Mattawan, MI, United States
[11]
发布时间
2013-11-20
换一批
